Literature DB >> 3093544

Treating erythema chronicum migrans of Lyme disease.

B W Berger.   

Abstract

The efficacy of antibiotic treatment of 117 patients with erythema chronicum migrans of Lyme disease was evaluated in terms of the necessity for retreatment and the prevention of the late manifestations of Lyme disease. Fifty-six patients with a minor form of the illness did not require retreatment and did not develop late manifestations following antibiotic treatment. Three pregnant patients were included in this group. Fourteen of sixty-one patients with a major form of the illness required retreatment, and five developed posttreatment late manifestations of Lyme disease consisting of Bell's palsy and persistent joint pain. Although the preferred antibiotic for treating erythema chronicum migrans of Lyme disease has not been conclusively established, tetracycline and penicillin proved effective. The use of probenecid plus penicillin may be of benefit to patients with the major form of the illness.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3093544     DOI: 10.1016/s0190-9622(86)70194-1

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  4 in total

1.  Molecular analysis of neutralizing epitopes on outer surface proteins A and B of Borrelia burgdorferi.

Authors:  J Ma; C Gingrich-Baker; P M Franchi; P Bulger; R T Coughlin
Journal:  Infect Immun       Date:  1995-06       Impact factor: 3.441

2.  Azithromycin versus doxycycline for treatment of erythema migrans: clinical and microbiological findings.

Authors:  F Strle; V Preac-Mursic; J Cimperman; E Ruzic; V Maraspin; M Jereb
Journal:  Infection       Date:  1993 Mar-Apr       Impact factor: 3.553

Review 3.  Cutaneous manifestations of Lyme borreliosis.

Authors:  E Aberer; H Klade
Journal:  Infection       Date:  1991 Jul-Aug       Impact factor: 3.553

4.  Evaluation of central nervous system involvement in Lyme borreliosis patients with a solitary erythema migrans lesion.

Authors:  H Kuiper; B M de Jongh; A P van Dam; D E Dodge; A C Ramselaar; L Spanjaard; J Dankert
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-05       Impact factor: 3.267

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.